SEOUL -- South Korean drugmaker Samsung Biologics will begin producing the Moderna coronavirus vaccine following an agreement struck during President Moon Jae-in's trip to Washington last week.
The company will produce hundreds of millions of vaccine doses at its facilities in Incheon and plans to ship the drug domestically and to other destinations excluding the U.S., according to Sunday's announcement.
